vs
Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and GYRE THERAPEUTICS, INC. (GYRE). Click either name above to swap in a different company.
CBAK Energy Technology, Inc. is the larger business by last-quarter revenue ($58.8M vs $37.2M, roughly 1.6× GYRE THERAPEUTICS, INC.). GYRE THERAPEUTICS, INC. runs the higher net margin — -3.7% vs -12.5%, a 8.9% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs 33.4%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $-5.8M). Over the past eight quarters, GYRE THERAPEUTICS, INC.'s revenue compounded faster (17.0% CAGR vs -0.0%).
CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
CBAT vs GYRE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.8M | $37.2M |
| Net Profit | $-7.4M | $-1.4M |
| Gross Margin | 7.3% | 95.3% |
| Operating Margin | -13.6% | 0.3% |
| Net Margin | -12.5% | -3.7% |
| Revenue YoY | 131.8% | 33.4% |
| Net Profit YoY | -63.6% | -340.1% |
| EPS (diluted) | $-0.08 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.8M | $37.2M | ||
| Q3 25 | $60.9M | $30.6M | ||
| Q2 25 | $40.5M | $26.8M | ||
| Q1 25 | $34.9M | $22.1M | ||
| Q4 24 | $25.4M | $27.9M | ||
| Q3 24 | $44.6M | $25.5M | ||
| Q2 24 | $47.8M | $25.2M | ||
| Q1 24 | $58.8M | $27.2M |
| Q4 25 | $-7.4M | $-1.4M | ||
| Q3 25 | $2.7M | $5.9M | ||
| Q2 25 | $-3.1M | $1.6M | ||
| Q1 25 | $-1.6M | $3.7M | ||
| Q4 24 | $-4.5M | $569.0K | ||
| Q3 24 | $17.6K | $2.9M | ||
| Q2 24 | $6.4M | $4.5M | ||
| Q1 24 | $9.8M | $9.9M |
| Q4 25 | 7.3% | 95.3% | ||
| Q3 25 | 8.0% | 94.7% | ||
| Q2 25 | 11.0% | 95.7% | ||
| Q1 25 | 13.7% | 95.9% | ||
| Q4 24 | 13.1% | 95.8% | ||
| Q3 24 | 15.6% | 96.2% | ||
| Q2 24 | 26.6% | 96.9% | ||
| Q1 24 | 31.9% | 96.4% |
| Q4 25 | -13.6% | 0.3% | ||
| Q3 25 | -6.6% | 22.7% | ||
| Q2 25 | -8.7% | 8.1% | ||
| Q1 25 | -8.2% | 10.3% | ||
| Q4 24 | -26.0% | 2.4% | ||
| Q3 24 | -1.9% | 16.6% | ||
| Q2 24 | 12.4% | 12.7% | ||
| Q1 24 | 17.4% | 29.7% |
| Q4 25 | -12.5% | -3.7% | ||
| Q3 25 | 4.4% | 19.4% | ||
| Q2 25 | -7.6% | 5.9% | ||
| Q1 25 | -4.5% | 16.9% | ||
| Q4 24 | -17.8% | 2.0% | ||
| Q3 24 | 0.0% | 11.2% | ||
| Q2 24 | 13.5% | 18.0% | ||
| Q1 24 | 16.7% | 36.6% |
| Q4 25 | $-0.08 | $-0.01 | ||
| Q3 25 | $0.03 | $0.03 | ||
| Q2 25 | $-0.03 | $0.00 | ||
| Q1 25 | $-0.02 | $0.00 | ||
| Q4 24 | $-0.05 | $0.00 | ||
| Q3 24 | $0.00 | $0.01 | ||
| Q2 24 | $0.07 | $0.01 | ||
| Q1 24 | $0.11 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.3M | $52.4M |
| Total DebtLower is stronger | $4.1M | — |
| Stockholders' EquityBook value | $112.7M | $106.0M |
| Total Assets | $426.2M | $166.1M |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.3M | $52.4M | ||
| Q3 25 | $10.5M | $60.0M | ||
| Q2 25 | $45.7M | $54.4M | ||
| Q1 25 | $9.6M | $29.9M | ||
| Q4 24 | $11.0M | $26.7M | ||
| Q3 24 | $24.2M | $25.1M | ||
| Q2 24 | $44.1M | $25.1M | ||
| Q1 24 | $23.8M | $37.4M |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $4.8M | — | ||
| Q2 25 | $4.9M | — | ||
| Q1 25 | $4.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $112.7M | $106.0M | ||
| Q3 25 | $121.4M | $101.9M | ||
| Q2 25 | $118.2M | $92.0M | ||
| Q1 25 | $120.8M | $68.1M | ||
| Q4 24 | $121.7M | $63.3M | ||
| Q3 24 | $131.2M | $63.2M | ||
| Q2 24 | $126.6M | $60.4M | ||
| Q1 24 | $120.9M | $56.6M |
| Q4 25 | $426.2M | $166.1M | ||
| Q3 25 | $363.9M | $159.4M | ||
| Q2 25 | $333.1M | $152.6M | ||
| Q1 25 | $311.5M | $129.8M | ||
| Q4 24 | $302.2M | $125.4M | ||
| Q3 24 | $293.5M | $125.2M | ||
| Q2 24 | $279.6M | $120.9M | ||
| Q1 24 | $286.5M | $122.0M |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.8M | $-5.6M |
| Free Cash FlowOCF − Capex | $16.1M | $-5.8M |
| FCF MarginFCF / Revenue | 27.3% | -15.5% |
| Capex IntensityCapex / Revenue | 23.4% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $3.9M | $-180.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.8M | $-5.6M | ||
| Q3 25 | $14.6M | $4.7M | ||
| Q2 25 | $13.8M | $2.1M | ||
| Q1 25 | $-9.6M | $-129.0K | ||
| Q4 24 | $9.6M | $-2.8M | ||
| Q3 24 | $19.7M | $1.7M | ||
| Q2 24 | $2.9M | $-5.5M | ||
| Q1 24 | $7.4M | $2.9M |
| Q4 25 | $16.1M | $-5.8M | ||
| Q3 25 | $6.0M | $4.0M | ||
| Q2 25 | $4.1M | $1.8M | ||
| Q1 25 | $-22.3M | $-251.0K | ||
| Q4 24 | $3.9M | $-2.8M | ||
| Q3 24 | $16.5M | $1.0M | ||
| Q2 24 | $2.5M | $-6.9M | ||
| Q1 24 | $-454.0K | $2.7M |
| Q4 25 | 27.3% | -15.5% | ||
| Q3 25 | 9.9% | 13.1% | ||
| Q2 25 | 10.2% | 6.8% | ||
| Q1 25 | -63.9% | -1.1% | ||
| Q4 24 | 15.5% | -10.1% | ||
| Q3 24 | 37.1% | 4.1% | ||
| Q2 24 | 5.2% | -27.5% | ||
| Q1 24 | -0.8% | 9.8% |
| Q4 25 | 23.4% | 0.4% | ||
| Q3 25 | 14.1% | 2.2% | ||
| Q2 25 | 23.8% | 1.0% | ||
| Q1 25 | 36.3% | 0.6% | ||
| Q4 24 | 22.5% | 0.2% | ||
| Q3 24 | 7.0% | 2.7% | ||
| Q2 24 | 0.9% | 5.8% | ||
| Q1 24 | 13.4% | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | 5.51× | 0.79× | ||
| Q2 25 | — | 1.32× | ||
| Q1 25 | — | -0.03× | ||
| Q4 24 | — | -4.85× | ||
| Q3 24 | 1115.72× | 0.60× | ||
| Q2 24 | 0.46× | -1.21× | ||
| Q1 24 | 0.76× | 0.29× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAT
| Manufacturing Lithium Batteries | $28.0M | 48% |
| Residential Energy Supply And Uninterruptable Supplies | $17.8M | 30% |
| Light Electric Vehicles | $12.9M | 22% |
| Precursor | $108.0K | 0% |
GYRE
Segment breakdown not available.
